title: Hepatitis C antiviral response in thalassemia: what is the role of liver iron concentration?
authors.forename: Ali T
authors.initials: AT
authors.lastname: Taher
authors.forename: Khaled M
authors.initials: KM
authors.lastname: Musallam
authors.forename: Mohamad
authors.initials: M
authors.lastname: Khalife
authors.forename: Kassem
authors.initials: K
authors.lastname: Barada
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D000077588:Deferasirox; D006526:Hepatitis C / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007501:Iron / Q000032:analysis; D007502:Iron Chelating Agents / Q000627:therapeutic use; D008099:Liver / Q000378:metabolism; D008297:Male; D013789:Thalassemia / Q000150:complications* / Q000188:drug therapy*; D016896:Treatment Outcome; D014230:Triazoles / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D007501:Iron; D000077588:Deferasirox